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Abstract:
Neisseria gonorrhoeae is the pathogen responsible for the sexually
transmitted infection gonorrhea. Since gonorrhea is a prevalent infection disease,
many antibiotics such as penicillin and ceftriaxone have been used to fight the
bacterium, and treat the infection. However, a vaccine has yet to be discovered
that can potentially prevent the infection from initially occurring. Due to the
constant variability of the pilus structure of the bacterium, Neisseria gonorrhoeae
is extremely difficult to develop a vaccine for. Periodically, the bacterium will alter
the structure of the pilus by slightly varying the genomic sequence responsible
for making the pilE polypeptide. This occurs through a process called genetic
recombination. In N. gonorrhoeae, there are a set of transcriptionally silent
genes, called the p/VS genes, which translocate a segment of their DNA, into the
variable regions of the pilE gene. This process of genetic recombination is
dependent on the RecA protein. Very little is known is about transcriptional
regulation of the p//E gene. During our studies on p//E gene expression, mRNA
sequences very similar to the p//S loci were shown being transcribed leading to
the possibility that the p//S sequences are perhaps transcriptionally active,
indicating possible promoter sites within the loci. Using the program Artemis, two
such possible promoter sites in p//S 2 were indicated. Site directed mutagenesis
to slightly alter the potential promoter sites will determine whether or not the sites
can be confirmed as promoter sites. Following mutagenesis, if mRNA is absent,
then this will indicate that the p//S genes are indeed being transcribed.

Introduction:
Neisseria gonorrhoea is the bacterial pathogen responsible for the
sexually transmitted infection gonorrhea. According to the Centers for Disease
Control, there are approximately 700,000 new cases of gonorrhea in the United
States alone. Numerous antibiotics such as ceftriaxone and azitrhomyecin have
been administered and, in the past, have been very successful in treating the
infection. More recently however, due to bacterial antibiotic resistance, there are
a growing number of cases where these antibiotics are not effective in killing the
bacteria. Initially, the drug is administered to a patient who is then cured from the
infection. However, there remain a few cells, not numerous enough to cause
adverse effects, which have the antibiotic resistant genes that can be passed on
to other cells. The most common way of gaining antibiotic resistance for bacterial
species in nature is by conjugation. In this process, bacterial cells having the
gene for the antibiotic resistance replicate the DNA, and transfers one copy of
the gene to another cell, using the pilus structure. In Neisseria gonorrhoeae, the
pilus structure, called the type IV pilus, is of particular importance due to its
antigenic variation capabilities. Antigenic variation is the slight change in the
sequence of the DNA of the bacterial species to evade the immune system of the
human body. The type IV pilus of N. gonorrhoeae is made up of several different
polypeptide subunits, one of which is the pilE polypeptide. Encoded by the pilE
gene, the pilE polypeptide houses the epitope, or the antigenic determinant
region, of the pilus structure. Variations of the pilus structure can be created by
translocating variable regions of pHE gene with a set of silent loci called the p//S,

or silent, genes. With a slightly different genomic sequence, leading to a different
epitope, the bacterial species can remain unrecognized by the immune system of
the body, and thus continue to be pathogenic to humans. This antigenic variation
is one of the key reasons to the lack of success in developing a vaccine to
prevent the infection. With constantly changing epitope regions, it is nearly
impossible to create all the possible combinations of epitopes the pilus can
attain. While looking at the translocation of the p//S genes into the p//E gene and
promoter elements in the p//E gene, Dr. Stuart Hill detected mRNA signal
indicating sequences similar to the p//S loci of the bacteria. This led to the
possibility of not only promoter elements in the p/7E gene, but also in the p/'/S loci,
thus leading to transcription of these supposedly silent genes. The goal of my
project was to locate and identify possible promoter sites in both FA1090 and
MS11 strains of N. gonorrhoeae and to confirm whether these potential sites
could be actual promoter elements.
Computer Analysis:
The first part of the experiment consisted of trying to locate potential promoter
sites in the FA1090 and MS11 strains of N. gonorrhoeae. I used the program
Artemis, to locate where mRNA signal was coming from, and tried to pinpoint the
exact sequence for the location of the signal. The -10 region of possible promoter
elements would be located 10 base pairs upstream of this start site, and this
sequence was what I tried to identify.
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Above: Screenshot of the program Artemis, with pilS 2 being shown in the middle of the screen.
The gene is on the top strand, and the corresponding green and red peaks at the top of the page
refer to the level of mRNA signal coming from those genes. The green is sense signal, while red
is antisense.

There are two types of mRNA that could be transcribed, sense and antisense.
Sense mRNA refers to mRNA that can be further translated Into protein, and Is
the traditional mRNA sequence. Antisense mRNA is a type of regulatory
sequence that can bind to DNA and inhibit further transcription from taking place.
Since sense mRNA was more prevalent in these pilS loci, I focused more on
possible promoters transcribing sense mRNA.

The p//S loci:
The pilS loci (multiple set of genes) are a unique set of genes in N. gonorrhoeae
that were originally thought to be transcriptionally silent. Interspersed among the
variable regions of the gene, there lie specific sequences that are shared among
all the different pilS genes. Thus, you get a mixture of variable regions, called
mini cassettes, surrounded by constant regions. A general schematic of a pilS
locus can be created, like the following:

p it S L o c u s In Neisseria g on o rrh o eae

Under normal environment conditions, various sections of the pilS gene are
translocated into the p//E gene, which goes on to be transcribed. These aide the
bacterial cell in antigenic variation, as the piE gene encodes for the major
subunit of the pilus structure, the piE polypeptide. The piE polypeptide houses
the epitope, or the antigenic determinant region, of the cell, and by slightly
altering the epitope, by altering the pilE polypeptide, the cell can evade the
human body's immune system and remain unrecognized.

Computer Analysis Continued:
After going through and analyzing Artemis to locate potential promoter sites on
the FA1090 strain of N. gonorrhoeae, I created a schematic to determine where
in the pilS loci these potential promoter sites lie:

There were 3 potential promoter sites located within the same conserved region
of the pilS loci, MS11 pilS 6, and FA1090 pilS 2 Sense #1 and, pilS 9 sense #3.
Focusing in on the sequence in these areas shows the exact same -10 region,
and very similar -35 regions for the possible promoter site:

FA1090 PilS Locus in Neisseria gonorrhoeae
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MS11 PilS 6
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TCAACCTGCCGTTGCTTTCAAATCGGTTCGGTAAAATGGTTCTGCGGACAGCCG

FA1090 PilS 9 Sense #3 TCTCCCTGTGGGCCAAGCGTGAAAACGGTTCGGTAAAATGGTTCTGCGGACAGC

FA1090 Pils 2 Sense # 1 TCTCCCIGTGGGCCAGGCGTCAAGACGGTTCGGTAAAAT GGTTCTGCGACAGC
Key: Bold - -10 region; Underlined and Italicized - 5’ end of transcription start site; Underlined - -35 region

Jenny McConoughey, a Ph. D. student in Dr. Hill’s lab, works on MS11 piiS 6 and
has almost fully confirmed a potential promoter site in that region, giving us great
reason to believe that other pilS genes with nearly identical sequences can also
be promoter elements.

Primer Extension Analysis:
Along with Artemis, another technique used to locate mRNA signal sites was
primer extension analysis. Dr. Hill analyzed the MS11 pilS 2 locus, inserted in
both the pSmart and TA vectors, to identify transcription start signals in order to
locate promoter elements in the pilS 2 loci.
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Above: Primer Extension Analysis showing transcription start-sites. The highest peaks, with their
respective colors, correspond to each individual base (A, G, C, and T).

The figure above shows data from the primer extension analysis of the p/7S 2
gene in the pSmart vector. The yellow shaded regions of the graph indicate the
relative transcription start sites. 10 and 35 bases upstream would indicate
potential -10 and -35 regions, respectively, of the promoter site. Complete
analysis of the primer extension indicated two potential sense promoters near the
3' end of the gene. One potential promoter site resembled the canonical bacterial
prom oter-10 sequence (TATAAT), with the other promoter being within 30 base
pairs of that one. This close proximity combined with the high similarity of one
potential promoter to the canonical promoter sequence in bacteria, led us to
believe with great confidence that at least one of the two is an actual promoter.
Thus, experimental analysis was done on these two sequences.
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-5 5 rciiu it
TCrCCCT
CTOATTC
TAACGAC
TCCTTTT
TGOTTCT
Not fcund.
Not fcund
TTCAAAC
TOTCT

-LO tctiun
TAAAAT
TAAT3TT
AACATT
GGTATT
O ACAA
AACA AC
AACAACAOTATT
T AAAAT

S in . site
CAGCC
CTTO A
G CCAA
A A TC A
CG TC0
CACCA
CCAAG
CGAAX
CtCCtAC

Above: Table showing potential promoter sites, with their respective -10 and -35 sequences, in
both MS11 and FA1090 strains of N. gonorrhoeae.
Below: M S11 pilS 2 potential promoter sites in bold.
Potential Promoter Element Sites in MS11 pilS 2
CGG CGG CCT GAA AAT CAC TTA CCG GCA GAT GAA GTG TCG CGG
C A G G TTG

Sequence
Mutation 2
location
Mutation 2
complimentary
strand
Mutation 1
location
Mutation 1
complimentary
strand

TTC ATC TGC CGG TAA GTG AGA TCT AGG CCG CCG GAA GCC GAA
TTC

In Bold

Location of potential promoter element’s -10 region

CAA CCT GCC GCG ACA AGA TCT CTG CCG GTA AGT GAT TTT CAG
GCC GCCG
GAA TTC GGC TTC CGG CGG CCT GAA AAT CAC TTA CCG GCA GAT
GAA

Experimental Analysis:
Due to great similarity between the canonical promoter sequence in bacteria, and
the potential promoter site in pilS 2, experimental analysis was done on the near
canonical potential promoter, and the potential promoter within 30 base pairs of
that one. The goal of the project was to mutate the potential promoter element,
and verify presence or absence of transcription signal. If mRNA signal ceases to
exist, then the mutated promoter site, in its unmutated form is an actual promoter
element. If not, then presence of transcription signal is not due to that sequence,
and there is another underlying cause to the signal, still yet to be determined.
Step 1: Insert pilS 2 gene into a vector.

In order for the gene to be mutated, the pilS 2 gene must be inserted into a
vector (plasmid). Another undergraduate student had previously cloned the pilS 2
gene into two different vectors, pSmart and TA. TA and pSmart vectors are
general plasmids that E. coli has the ability to uptake during transformation.
Thus, a gene cloned into either TA or pSmart has the potential to be expressed.
The first step of my experimental analysis was to determine which vector to use.
Thus, I had to confirm that the gene had been properly inserted into the vectors.
The portion of pilS 2 that I was working with was around 250 base pairs long.
Using primers flanking the TA and pSmart vectors for a total size of 100 base
pairs, I could determine the size of my insert and confirm if the size is correct
(around 350 base pairs):

vector, and SL1 and SR2 for the pSmart vector, the size of the insert can be
correctly calculated, confirming the insertion of the pilS 2 gene in either the TA or
pSmart vectors:

Above: Running the per products on a standard agarose gel showed that the pSmart insert was
not the right base pair size (showed at around 1000 bp), while the insert in TA was the correct
size (around 350 bp). Thus primers were designed for the p/'/S 2 gene inserted into the TA vector.

Step 2: Checking orientation of the p/'/S 2 insert in TA vector:
In order to mutate the p/'/S 2 gene, primers containing the mutated sequence had
to be designed. Thus, the first step was to design primers. Since the mutation is
towards the 3' (tail) end of the gene, there was significant concern for the primer
sequence not being long enough to anneal to the template. Thus, primers with
partial sequence in the p/'/S 2 gene, and partial sequence in the TA vector had to
be designed. However, in order to design primers using both the vector and the

gene, confirmation of the exact orientation of the gene within the vector had to
take place. The gene could have inserted into the vector in two possible
orientations. The first orientation, called the forward orientation, is when the 5'
end of the gene lines up with the 3' end of the vector. This way, the entire vector
plus gene is in a 5' to 3' direction, and thus is called forward. The opposite is the
reverse orientation, in which the 5' end of the gene correlates with the 5' end of
the vector. Checking for orientation is done by using pre made primers that are
within the gene and within the vector, in different combinations. To check for the
orientation of MS11 p//S2, primers MM13 Forward and Reverse, FC, and PilS2R
were used in different combinations. MM13 Forward is the primer on the 5' end of
the vector, while MM13 Reverse is on the 3' end. FC is the forward primer within
the pilS 2 gene, while PilS2R is the reverse primer within the gene. Combinations
of MM13 Forward with FC and MM13 Reverse with FC could tell us what
orientation the insert is in. If in the forward orientation, then per product will have
a band in the MM13 Reverse - FC combination. If in the reverse, the MM13
Forward - FC will have a band. The results indicated that the gene was cloned in
the reverse orientation, and thus new primers would have to be designed
accordingly:

FC primer (in p i IS 2)

Above: Orientation analysis of the pilS2 gene within the TA vector indicated the gene was cloned
in reverse orientation. This is because the reverse primers (MM13 Forward and FC) showed
product (band in the second lane).

Step 3: Design Primers Using p/VS 2 and TA vector:
Having confirmed the insert, as well as the orientation of the insert, primers
containing a mutation within the possible promoter element sequence were
designed. In order to be able to check for presence of mutation after per, primers
containing a signal marker needed to be created. Thus, primers containing the
sequence for a specific restriction enzyme, located in the vector at only one other
site, were to be created. This is so that if the mutation is in place, then performing
restriction digest on the vector + insert, will lead to two smaller fragments of DNA.

If the mutation doesn't get inserted, then the restriction enzyme will only cut the
circular plasmid at one site (on the vector), leading to a linearized (and still the
same size) vector. The restriction enzyme I chose for both my mutations was
BGL II. The sequence for this particular enzyme is AGATCT, and thus I designed
my primers to have that sequence at the mutation site:

BGL II - enzyme
used
TA + pilS2
MutF2
TA + pilS2
MutR2
TA + pilS2
M utFl
TA + pilS2
M utRl

Length
CGG CGG CCT GAA AAT CAC TTA CCG GCA GAG ATC TTG TCG CGG
CAG G TTG
CAA CCT GCC GCG ACA AGA TCT CTG CCG GTA AGT GAT TTT CAG
G CCG CCG
GAA TTC GGC TTC CGG CGG CCT AGA TCT CAC TTA CCG GCA GAT
GAA
TTC ATC TGC CGG TAA GTG AGA TCT AGG CCG CCG GAA GCC GAA
TTC

Tm

49

72.,5

49

72.,5

45

70.,5

45

70.,5

Step 4: Polymerase Chain Reaction (per) using mutated primers
Having designed primers with mutated base pairs, a per reaction using those
primers, and the DNA template was required to create a new mutated strand of
DNA. Per reactions work by changing the temperature at which the reaction is
taking place, thus allowing different steps to occur sequentially. In the denature
phase, the temperature was raised to 98 degrees Celsius to separate the two
strands of the DNA template. In the next phase, the annealing phase, the
temperature is cooled down to 50 or 55 degrees Celsius to allow the primer
sequences to anneal to the template. In the final phase, the elongation phase,
the RNA polymerase adds additional nucleotides to the primer sequence to
create a new DNA strand. Each of the two original DNA strands is used as a
template, and thus the number of DNA strands at the end of 18 cycles increases

in an exponential manner (22 = 262,144 strands). The per reaction is used to
essentially quantify the DNA product, but in this case is also used to insert a
mutation in the DNA. After per, DPN I, a lyase enzyme, is used to break down the
original strand of DNA, so only the mutated strands remain. If performed
correctly, then a gel electrophoresis analysis will reveal a band at around 4 kb
(for the TA + p/VS 2 vector).

Results for per using mutated primers:
Lane 1
Ladder

Lane 2
Mut 1 - 1
-5 0
degrees

Lane 3
Mut 1 - 2
-5 0
degrees

Lane 4
Mut 2 - 1
-5 0
degrees

Lane 5
Mut 2 - 2
-5 0
degrees

Lane 6
Mut 1 55
degrees

Lane 7
Mut 2 55
degrees

Above: The ninth band from the bottom in the ladder signifies a DNA strand with a length of 4000
bp (4 kb). The products for all my reactions (the brighter bands on the top) were slightly above
that 4 kb band, or around 4.2 kb. This indicates that the per reaction was successful, and
transformation and digestion will be conducted to confirm insertion of mutation site in DNA.

Step 5: Transformation of per products into competent E. coli cells

In order to quantify the plasmid that was run in per, the plasmid needed to be
transformed into live E. coli cells, and the cells allowed to reproduce. Once a
colony of cells had grown, that colony was streaked onto another nutrient rich
agar plate, and grown more. That pure colony had the plasmid I desired in
copious amounts. After transformation, extraction of plasmid from the colony of
cells, and digestion of that plasmid was performed, to reveal whether my mutation
was successful. If the plasmid was cleaved at two point using Bgl II, then two
smaller fragments would have appeared on the gel. This would indicate that the
mutation I needed was successfully inserted into the p/'/S 2 gene.

Transformation Results:

Above: Transforming one of the Mutation # 2 per products into competent E. coli cells proved to
be very successful. There are many colonies that grew on the kanamycin plates. The TA vector

contains a kanamycin resistant gene, and thus any colony grown on the plate is presumed to
have taken up the plasmid and with it the kanamycin resistance gene.

While transformation seemed to be very successful, as noted by the vast amount
of colonies grown on the plate, this doesn’t prove that the mutation had been
inserted into the pilS 2 gene. The mutation could have been eliminated by proof
reading enzymes, or simply not been in the plasmid that was taken up by the
competent cells. Thus, in order to check for successful mutation, digestion with
Bgl II must take place. I specifically chose Bgl II as the restriction enzyme
because there was only one other Bgl II site in the TA vector. By adding a Bgl II
restriction sequence as my mutation, a successful insertion of the mutation will
reveal two restriction sites for Bgl II. When performing digestion, this will reveal
two smaller fragments of DNA that will add up to around 4.2 kb, or the size of my
entire plasmid. In order to gather enough plasmid to extract and digest, single
transformation colonies were hand picked and streaked onto more kanamycin
plates to grow further:

Above: Colonies streaked onto kanamycin plates in order to grow more for extraction and
eventual digestion of plasmid.

Digestion Results:

Digestion Results:
Unfortunately, the insertion of the mutation site proved to be unsuccessful as all
digestion products either showed bands around 4.2 kb, meaning they were only
linearized due to single digestion, or didn’t show up at all. Due to lack of time, this
was as far as the project was able to go, and mutations were not successfully
accomplished.

Conclusion:
In conclusion, this project had its ups and downs as the search for a potential
promoter site proved to be more difficult than originally anticipated. The project

started out with a critical mistake when halfway through the semester, it was
determined that the wrong insert was used when working with the pSmart vector.
Originally, this vector plus insert was believed to have the the pilS 2 insert
between the FC and CR primer locations, a length of about 250 bp. However,
after per analysis using the two primers, it was determined to have a size of
about 1000 bp, thus not being the insert we needed. Unfortunately, I had
designed primers and worked with this clone for about half the semester. Luckily,
the pilS 2 insert was also cloned into the TA vector and this became the primary
plasmid used from then on. I determined the orientation of the insert to be in the
reverse orientation, and thus designed primers accordingly. However, after
several rounds of per, I still was not getting any product, and was confused as to
why this was. Thao, a Ph. D. student in Dr. Hill’s lab then explained to me that it
was due to the elongation time not being long enough (1 minute instead of 2
minutes). After making the proper adjustments, I finally attained per product, and
performed transformation. With a very successful transformation, I extracted the
plasmid and digested it, in hopes of confirming the mutation of an insert.
However, digestion results revealed that my mutation had either not been
inserted or been deleted after it was inserted. At this time, the semester had
concluded, and my project was complete. While I did not get to my goal of
attaining a mutation in the pilS 2 gene of the MS11 strain of Neisseria
gonorrhoeae, the project was by no means unsuccessful. Along with learning
many new techniques such as per reaction, site directed mutagenesis, and
restriction digestion, I also gained key information on the mechanisms of

bacterial replication and DNA recombination. As for the project, there are still
other Masters and Ph. D. students in Dr. Hill’s lab that continue to work on p/'/S
and p/VE genes to find potential promoter sites. Hopefully one day, there will be
full confirmation of promoter sites within the p//S loci of A/, gonorrhoeae and
further work to develop a vaccine can be conducted. I would like to thank the
Honors department at Northern Illinois University and Dr. Stuart Hill for allowing
me to work on and fund this great project throughout my undergraduate career. It
was a great learning experience, and I am confident the techniques I learned in
Dr. Hill’s lab will serve me well in the future. Thank you!
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